Terms: = Prostate cancer AND NCOR1, hCIT529I10, 9611, ENSG00000141027, N-CoR, MGC104216, TRAC1, O75376, hN-CoR, KIAA1047
37 results:
1. Third generation quinoline-3-carboxamide transcriptional disrupter of HDAC4, HIF-1α, and MEF-2 signaling for metastatic castration-resistant prostate cancer.
Isaacs JT; Dalrymple SL; Antony L; Marc Rosen D; Coleman IM; Nelson PS; Kostova M; Murray IA; Perdew GH; Denmeade SR; Akinboye ES; Brennen WN
Prostate; 2023 Nov; 83(15):1470-1493. PubMed ID: 37559436
[TBL] [Abstract] [Full Text] [Related]
2. Synthesis and Evaluation of
Lu K; Zhang C; Zhang Z; Kuo HT; Colpo N; Bénard F; Lin KS
Molecules; 2023 Jun; 28(13):. PubMed ID: 37446782
[TBL] [Abstract] [Full Text] [Related]
3. Circulating Tumor Cell Genomic Evolution and Hormone Therapy Outcomes in Men with Metastatic Castration-Resistant prostate cancer.
Gupta S; Halabi S; Kemeny G; Anand M; Giannakakou P; Nanus DM; George DJ; Gregory SG; Armstrong AJ
Mol Cancer Res; 2021 Jun; 19(6):1040-1050. PubMed ID: 33771885
[TBL] [Abstract] [Full Text] [Related]
4. ncor1 may be a potential biomarker of a novel molecular subtype of prostate cancer.
Tang L; Zhang L; Liu L; Dong L; Dong Y; Zhu W; Wang H
FEBS Open Bio; 2020 Dec; 10(12):2678-2686. PubMed ID: 33058520
[TBL] [Abstract] [Full Text] [Related]
5. The cancer driver genes IDH1/2, JARID1C/ KDM5C, and UTX/ KDM6A: crosstalk between histone demethylation and hypoxic reprogramming in cancer metabolism.
Chang S; Yim S; Park H
Exp Mol Med; 2019 Jun; 51(6):1-17. PubMed ID: 31221981
[TBL] [Abstract] [Full Text] [Related]
6. A genome-wide analysis of colorectal cancer in a child with Noonan syndrome.
Prasad RM; Mody RJ; Myers G; Mullins M; Naji Z; Geiger JD
Pediatr Blood Cancer; 2018 Nov; 65(11):e27362. PubMed ID: 30039904
[TBL] [Abstract] [Full Text] [Related]
7. Outdoor air pollution, green space, and cancer incidence in Saxony: a semi-individual cohort study.
Datzmann T; Markevych I; Trautmann F; Heinrich J; Schmitt J; Tesch F
BMC Public Health; 2018 Jun; 18(1):715. PubMed ID: 29884153
[TBL] [Abstract] [Full Text] [Related]
8. JS-K, a nitric oxide pro-drug, regulates growth and apoptosis through the ubiquitin-proteasome pathway in prostate cancer cells.
Tan G; Qiu M; Chen L; Zhang S; Ke L; Liu J
BMC Cancer; 2017 May; 17(1):376. PubMed ID: 28549433
[TBL] [Abstract] [Full Text] [Related]
9. SFMBT2 (Scm-like with four mbt domains 2) negatively regulates cell migration and invasion in prostate cancer cells.
Gwak J; Shin JY; Lee K; Hong SK; Oh S; Goh SH; Kim WS; Ju BG
Oncotarget; 2016 Jul; 7(30):48250-48264. PubMed ID: 27340776
[TBL] [Abstract] [Full Text] [Related]
10. Nuclear Receptor Corepressor 1 Expression and Output Declines with prostate cancer Progression.
Lopez SM; Agoulnik AI; Zhang M; Peterson LE; Suarez E; Gandarillas GA; Frolov A; Li R; Rajapakshe K; Coarfa C; Ittmann MM; Weigel NL; Agoulnik IU
Clin Cancer Res; 2016 Aug; 22(15):3937-49. PubMed ID: 26968201
[TBL] [Abstract] [Full Text] [Related]
11. Whole transcriptome sequencing reveals extensive unspliced mRNA in metastatic castration-resistant prostate cancer.
Sowalsky AG; Xia Z; Wang L; Zhao H; Chen S; Bubley GJ; Balk SP; Li W
Mol Cancer Res; 2015 Jan; 13(1):98-106. PubMed ID: 25189356
[TBL] [Abstract] [Full Text] [Related]
12. Commentary on "the E3 ubiquitin ligase Siah2 contributes to castration-resistant prostate cancer by regulation of androgen receptor transcriptional activity." Qi J, Tripathi M, Mishra R, Sahgal N, Fazli L, Ettinger S, Placzek WJ, Claps G, Chung LW, Bowtell D, Gleave M, Bhowmick N, Ronai ZA, Signal Transduction Program, cancer Center, Sanford-Burnham Medical Research Institute, La Jolla, CA, USA.: cancer Cell 2013;23(6):332-46.
Olumi AF
Urol Oncol; 2014 Feb; 32(2):210-1. PubMed ID: 24445292
[TBL] [Abstract] [Full Text] [Related]
13. The E3 ubiquitin ligase Siah2 contributes to castration-resistant prostate cancer by regulation of androgen receptor transcriptional activity.
Qi J; Tripathi M; Mishra R; Sahgal N; Fazli L; Ettinger S; Placzek WJ; Claps G; Chung LW; Bowtell D; Gleave M; Bhowmick N; Ronai ZA
Cancer Cell; 2013 Mar; 23(3):332-46. PubMed ID: 23518348
[TBL] [Abstract] [Full Text] [Related]
14. The effects of dutasteride and finasteride on BPH-related hospitalization, surgery and prostate cancer diagnosis: a record-linkage analysis.
Cindolo L; Fanizza C; Romero M; Pirozzi L; Autorino R; Berardinelli F; Schips L
World J Urol; 2013 Jun; 31(3):665-71. PubMed ID: 23239103
[TBL] [Abstract] [Full Text] [Related]
15. Tasquinimod Is an Allosteric Modulator of HDAC4 survival signaling within the compromised cancer microenvironment.
Isaacs JT; Antony L; Dalrymple SL; Brennen WN; Gerber S; Hammers H; Wissing M; Kachhap S; Luo J; Xing L; Björk P; Olsson A; Björk A; Leanderson T
Cancer Res; 2013 Feb; 73(4):1386-99. PubMed ID: 23149916
[TBL] [Abstract] [Full Text] [Related]
16. Epigenetic distortion to VDR transcriptional regulation in prostate cancer cells.
Singh PK; Doig CL; Dhiman VK; Turner BM; Smiraglia DJ; Campbell MJ
J Steroid Biochem Mol Biol; 2013 Jul; 136():258-63. PubMed ID: 23098689
[TBL] [Abstract] [Full Text] [Related]
17. The l58Val/Met polymorphism of catechol-O-methyl transferase gene and prostate cancer risk: a meta-analysis.
Xiao L; Tong M; Jin Y; Huang W; Li Z
Mol Biol Rep; 2013 Feb; 40(2):1835-41. PubMed ID: 23096092
[TBL] [Abstract] [Full Text] [Related]
18. Recruitment of ncor1 to VDR target genes is enhanced in prostate cancer cells and associates with altered DNA methylation patterns.
Doig CL; Singh PK; Dhiman VK; Thorne JL; Battaglia S; Sobolewski M; Maguire O; O'Neill LP; Turner BM; McCabe CJ; Smiraglia DJ; Campbell MJ
Carcinogenesis; 2013 Feb; 34(2):248-56. PubMed ID: 23087083
[TBL] [Abstract] [Full Text] [Related]
19. Androgen receptor coregulators NOCR1, TIF2, and ARA70 may account for the hydroxyflutamide insensitivity of prostate cancer cells.
Wang Y; Li JQ; Shao C; Shi CH; Liu F; Yang ZY; Qiu JX; Li YM; Fu Q; Zhang W; Xue W; Lei YH; Gao JY; Wang JY; Gao XP; Yuan JL; Bao TY; Zhang YT
Ir J Med Sci; 2011 Dec; 180(4):865-72. PubMed ID: 21748440
[TBL] [Abstract] [Full Text] [Related]
20. Formation of AR-SMRT binding in prostate cancer cells treated with natural histone deacetylase inhibitor.
Trtková K; Pašková L; Matiješčuková N; Kolář Z
Cancer Biomark; 2010; 7(2):79-90. PubMed ID: 21178266
[TBL] [Abstract] [Full Text] [Related]
[Next]
